• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

Chemical Profile of Racemic 3-Acetamidononan-2-one (CAS No. 51714-09-1)

Racemic 3-Acetamidononan-2-one, identified by its Chemical Abstracts Service (CAS) number 51714-09-1, is a significant compound in the realm of organic chemistry and pharmaceutical research. This enantiomeric mixture holds considerable interest due to its structural complexity and potential applications in synthetic chemistry and drug development.

The molecular structure of Racemic 3-Acetamidononan-2-one consists of a ketone group positioned at the second carbon atom of a nonane chain, with an acetamidine moiety attached to the third carbon. This unique arrangement imparts distinct reactivity and functionality, making it a valuable intermediate in various chemical transformations. The compound's stereochemistry, being racemic, means it contains equal proportions of both enantiomers, which can influence its interactions with biological systems.

In recent years, there has been growing attention on the applications of such chiral compounds in medicinal chemistry. The study of racemic mixtures like Racemic 3-Acetamidononan-2-one provides insights into the importance of stereochemistry in drug design. Researchers have been exploring its potential as a precursor in the synthesis of more complex molecules, particularly those with pharmacological activity. The compound's ability to undergo selective reactions under controlled conditions makes it a promising candidate for further investigation.

One of the most compelling aspects of 3-Acetamidononan-2-one is its role in the development of novel therapeutic agents. Its structural framework can be modified to create derivatives with enhanced biological activity. For instance, modifications at the acetamidine group have shown promise in the synthesis of compounds with antimicrobial and anti-inflammatory properties. These findings highlight the compound's versatility and its potential as a building block for future drug candidates.

The synthesis of racemic mixtures often presents challenges due to the need for precise control over stereochemical outcomes. However, advances in synthetic methodologies have made it increasingly feasible to produce such compounds with high purity and yield. Techniques such as asymmetric synthesis and chiral resolution have enabled researchers to isolate individual enantiomers, which can then be studied separately for their unique properties. This approach has opened new avenues for exploring the therapeutic potential of Racemic 3-Acetamidononan-2-one.

The chemical reactivity of 3-Acetamidononan-2-one also makes it an interesting subject for studying reaction mechanisms and catalytic processes. Its ketone group can participate in various transformations, including oxidation, reduction, and condensation reactions, while the acetamidine moiety offers additional sites for functionalization. These properties have been exploited in developing new synthetic routes to complex organic molecules, demonstrating the compound's importance beyond its potential pharmaceutical applications.

In conclusion, Racemic 3-Acetamidononan-2-one (CAS No. 51714-09-1) is a multifaceted compound with significant implications in organic chemistry and drug development. Its unique structural features and reactivity make it a valuable intermediate for synthesizing more complex molecules with potential therapeutic benefits. As research continues to uncover new applications for this compound, its importance in the chemical and pharmaceutical industries is likely to grow further.

• 30057-76-2(N-(2-Oxoheptan-3-yl)acetamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)